Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹285.9 Cr | ₹292.8 Cr | ₹514.3 Cr | ₹439.7 Cr |
| Net Profit | ₹27.8 Cr | ₹13.9 Cr | ₹96.9 Cr | ₹40.6 Cr |
| EPS | — | ₹10.83 | ₹75.49 | ₹31.62 |
| Operating Profit | ₹56 Cr | ₹42.3 Cr | ₹157.3 Cr | ₹85.2 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 18 Jul 2025 | Dividend - Rs 12 Per Share | DIVIDEND |
| 12 Jul 2024 | Annual General Meeting/Dividend - Rs 14 Per Share | AGM |
| 11 Jul 2023 | Annual General Meeting/Dividend - Rs 10 Per Share | AGM |
| 14 Jul 2022 | Annual General Meeting/Dividend - Rs 5 Per Share | AGM |
| 29 Jun 2021 | Annual General Meeting/Dividend - Rs 3 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NEULANDLAB
View All
Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4
Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and revenue year-on-year. This robust financial result was driven by strong business momentum across key segments. The company is also investing in future growth through strategic initiatives.
Neuland Laboratories shares in focus after a strong Q4 but Co warns of 'lumpy' numbers
Neuland Labs provides active pharmaceutical ingredients (APIs), complex intermediates, custom manufacturing solutions. The stock has risen over 18% in the last one month.
Stocks to Watch for May 13: Dixon, Neuland, Torrent Power, Tata Power, Bharti Airtel and more
Tata Power, Torrent Power and Dr. Reddy's report weaker Q4, Berger Paints, Neuland Laboratories, MTAR Technologies and Kalpataru Projects post strong gains, Vodafone Idea plans fundraise. Here are few stocks to keep an eye on ahead of Wednesday's trading session.